Global Degenerative Disk Disease Market, By Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine, Thoracic Spine, Spinal Fusion), End- Users (Hospitals, Clinics, Others), Product Type (ALLOB, AMG-0101, BRTX-100, OTICR-01, Others) – Industry Trends and Forecast to 2029.
Global Degenerative Disk Disease Market Analysis and Size
Degenerative disc disease can lead to multiple disorders, such as spondylolisthesis, retrospondylolisthesis and lumbar spinal stenosis. Approximately 90% of people witness an episode of debilitating back pain at a later point in their lives. Biopharmaceutical companies are currently targeting oral treatment and peripherally acting analgesics.
- The degenerative disk disease market was valued at USD 1.46 billion in 2021 and is expected to reach USD 1.95 billion by 2029, registering a CAGR of 3.60% during the forecast period of 2022-2029. Pharmaceutical Companies is expected to witness high growth owing to increase in the number of clinical approvals.
Global Degenerative Disk Disease Market Definition
Degenerative disc disease refers to the type of disease that incorporates regular changes that occur in human spinal discs as they age. The discs functions as shock absorbers for the human spine, that enables body to bend, flex and twist. Several other factors could be responsible for degenerative disc disease, including tears in the outer core of the disc during daily activities along with ageing.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Vacuum-assisted Biopsy Systems, Vacuum-assisted Biopsy Needles), Type (9-12G, <9G, >12G), Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, Others), Applications (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
B. Braun Melsungen AG (Germany), AxioMed LLC (US), Medical Devices Business Services, Inc. (US), Zimmer Biomet Spine, Inc. (US), Biomet (US), Medtronic (Ireland), Stryker (US), Ensol Biosciences Inc. (South Korea), U.S. Stem Cell, Inc (US), Kolon TissueGene, Inc. (US), Samumed, LLC. (US), BIOPHARM GmbH (Germany), SpineVision (France), Sarl COUSIN BIOTECH (France), Globus Medical (US), Paradigm Spine LLC (US), among others
|
|
Market Opportunities
|
|
In Vitro Diagnostic (IVD) Regulatory Affairs Outsourcing Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Prevalence of Degenerative Disk Diseases
The rise in the prevalence of degenerative disc disease, especially among geriatric population as they are more prone to the disease acts as one of the major factors driving the growth of degenerative disc disease market. The increase in the elderly population further assists in the growth of the market.
- Clinical Approvals
An increase in demand for degenerative disc disease treatment is being witnessed as companies are under constant pressure to procure enhanced treatment options for the affected individuals.
- Availability of both Non- Surgical and Spinal Fusion Process
The availability of both non- surgical and spinal fusion process for treatment of degenerative disk diseases, along with advancements in the processes further influence the market.
Opportunities
Furthermore, launch of innovative and technologically advanced products to meet the needs of customers extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, surge in investments will further expand the market.
Restraints/Challenges Global Degenerative Disk Disease Market
On the other hand, availability of alternative therapies such as physiotherapy and special exercises are expected to obstruct market growth. Also, dearth of proper reimbursement policy is projected to challenge the degenerative disc disease market in the forecast period of 2022-2029.
Covid-19 Impact on Degenerative Disk Disease Market
COVID-19 had a negative impact on the healthcare sector. Major Key players adapted innovative strategies to the rapidly changing situation during the outbreak of the COVID-19. Countries took critical healthcare changes until the crisis took a back seat. Healthcare reforms are expected to witness cost containment, increased access and technological progress in the coming years. . The implementation of social distancing, lockdown of the population and limited access to clinics greatly affected the market. The slow-down in patient flow and referrals, and decline in trauma and workplace injuries also impacted the market growth. However, market will resume its growth in the post-pandemic due to the easing in restrictions that were imposed earlier.
Recent Developments
- BioRestorative Therapies, Inc. announced regarding their collaboration with Dr. Tore Bengtsson, Professor of the Department of Molecular Biosciences, at the Wenner-Gren Institute, at Stockholm University March’2022. BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols under two core programs, including Disc/Spine Program (brtxDISC™) and Metabolic Program (ThermoStem®).
Global Degenerative Disk Disease Market Scope and Market Size
The degenerative disc disease market is segmented on the basis of treatment, end- users and product type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Artificial Disc Replacement
- Cervical Spine
- Lumbar Spine
- Thoracic Spine
- Spinal Fusion
On the basis of treatment, the degenerative disk disease market into artificial disc replacement, cervical spine, lumbar spine, thoracic spine and spinal fusion.
End- Users
- Hospitals
- Clinics
- Others
End- users segment of the degenerative disk disease market is segmented into hospitals, clinics, and others.
Type
- ALLOB
- AMG-0101
- BRTX-100
- OTICR-01
- Others
On the basis of type, the market is segmented into ALLOB, AMG-0101, BRTX-100, OTICR-01, and others.
Degenerative Disk Disease Market Regional Analysis/Insights
The degenerative disk disease market is analysed and market size insights and trends are provided by country, treatment, end- users and product type as referenced above.
The countries covered in the degenerative disk disease market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the degenerative disk disease market because of the presence of well-developed healthcare infrastructure within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in the geriatric population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The degenerative disk disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for degenerative disk disease market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the degenerative disk disease market. The data is available for historic period 2010-2020.
Competitive Landscape and Degenerative Disk Disease Market Share Analysis
The degenerative disk disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to degenerative disk disease market.
Some of the major players operating in the degenerative disk disease market are B. Braun Melsungen AG (Germany), AxioMed LLC (US), Medical Devices Business Services, Inc. (US), Zimmer Biomet Spine, Inc. (US), Biomet (US), Medtronic (Ireland), Stryker (US), Ensol Biosciences Inc. (South Korea), U.S. Stem Cell, Inc (US), Kolon TissueGene, Inc. (US), Samumed, LLC. (US), BIOPHARM GmbH (Germany), SpineVision (France), Sarl COUSIN BIOTECH (France), Globus Medical (US), Paradigm Spine LLC (US), among others.
Research Methodology : Global Degenerative Disk Disease Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-degenerative-disk-disease-market
SKU-